Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Better Late Than Never? Congress, Courts May Address Limits On Disseminating 'Off Label' Medical Information
Forbes
Thursday, October 16, 2014 - 6:41pm
tags:
off-label, US Congress, FDA
Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations
Yahoo
Thursday, October 16, 2014 - 6:37pm
tags:
Eli Lilly, Puerto Rico, drug manufacturing
FDA panel votes to keep severe warning on Pfizer anti-smoking drug
Yahoo/Reuters
Thursday, October 16, 2014 - 6:36pm
tags:
FDA, advisory panels, Pfizer, Chantix, smoking cessation, warnings
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy
TheStreet.com
Thursday, October 16, 2014 - 9:21am
tags:
BrainStorm Cell Therapeutics, ALS
Benefits of Novartis psoriasis drug outweighs risk: FDA staff
Yahoo/Reuters
Thursday, October 16, 2014 - 9:19am
tags:
Novartis, psoriasis, FDA, secukinumab
Medical products push Baxter profit above estimate
Yahoo/Reuters
Thursday, October 16, 2014 - 9:18am
tags:
Baxter International, earnings, devices
ConvaTec owners appoint banks to explore sale: sources
Mass Device
Thursday, October 16, 2014 - 9:17am
tags:
ConvaTec, M&A, devices
Eisai's Thyroid Cancer Drug Gets FDA Priority Review
Drug Discovery and Development
Thursday, October 16, 2014 - 9:13am
tags:
Eisai, thyroid cancer, FDA, Lenvatinib
Some in Ebola Trials Wouldn’t Get Test Drugs in U.S. Plan
Bloomberg
Thursday, October 16, 2014 - 8:18am
tags:
ebola virus, clinical trials, FDA, ethics
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy
Yahoo
Thursday, October 16, 2014 - 8:17am
tags:
Sanofi Pasteur, Immune Design, herpes simplex virus, R&D
Swiss drug maker Roche posts flat 9-month sales
Yahoo/AP
Thursday, October 16, 2014 - 7:49am
tags:
Roche
Was Celgene's Crohn's Disease Drug Worth The Price?
Investors.com
Thursday, October 16, 2014 - 7:48am
tags:
Celgene, Crohn's Disease, GED-0301
AbbVie Board Recommends Holders Vote Against Shire Deal
Bloomberg
Thursday, October 16, 2014 - 7:47am
tags:
AbbVie, Shire, tax inversions, M&A
Roche, Boehringer Drugs Wins Approval for Lung Disease
Bloomberg
Wednesday, October 15, 2014 - 4:49pm
tags:
Roche, Boehringer Ingelheim, FDA, IPF, idiopathic pulmonary fibros, Esbriet, Ofev
Merck unit to pay $31 mln to settle fraud claims by U.S. states
Yahoo/Reuters
Wednesday, October 15, 2014 - 4:43pm
tags:
Merck, Medicaid, Medicaid fraud, whistleblower lawsuits, Organon
AbbVie, Shire Have Options Besides Each Other: Real M&A
Bloomberg
Wednesday, October 15, 2014 - 2:54pm
tags:
M&A, AbbVie, Shire, tax inversions, Allergan, Valeant Pharmaceuticals
Should Gilead Sciences, inc. Fear Incoming Competition?
Motley Fool
Wednesday, October 15, 2014 - 2:51pm
tags:
Gilead Sciences, hepatitis C, AbbVie, Bristol-Myers Squibb
GSK starts unloading older meds by region, with $3B portfolio up for grabs
Fierce Pharma
Wednesday, October 15, 2014 - 1:18pm
tags:
GSK, reorganization
Here’s Why iBio’s Shares Are Plummeting
Bidness Etc.
Wednesday, October 15, 2014 - 1:13pm
tags:
iBio, Mapp Biopharmaceutical, ebola virus
Orexigen pockets $100M in milestone cash for Contrave
Fierce Biotech
Wednesday, October 15, 2014 - 12:26pm
tags:
Orexigen, Contrave, Takeda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.